SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jul 27, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The SIRI Checklist study is focused on improving HIV prevention and treatment for people living in rural areas who inject drugs. Researchers want to use a new checklist to help ensure that these individuals receive the right care, including long-acting injectable medicines that can prevent HIV. The main idea is that better hospital care can help connect people who use drugs to effective treatments for both addiction and the prevention of infections like HIV, ultimately helping to end the HIV epidemic in rural areas.
To be part of this study, participants need to be at least 18 years old, have a serious injection-related infection, and be receiving care at UAB Hospital. They must be HIV negative and have a diagnosis of opioid use disorder, which means they struggle with using opioids. Participants will be engaged in a supportive environment where they can receive care tailored to their needs. This research is important because it aims to create effective strategies for helping vulnerable populations access the healthcare they need.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • We will include 60 PWUD with serious injection related infections (SIRI) who are HIV negative, ≥ 18 years old, have opioid use disorder (OUD) and receiving care at UAB Hospital
- Exclusion Criteria:
- • We will exclude those unable to provide informed consent due to acute illness or intoxication, those who don't have OUD, and those who are HIV positive in order to inform HIV prevention interventions.
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials